Long-term follow-up for EXCELLENT trial participants
Part of Heart & circulation clinical trials.
This study looks at the long-term health of people who took part in the EXCELLENT trial. If you finished that trial within the last 10 years, you may be able to join this study to help researchers understand how participants are doing over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You took part in the EXCELLENT trial and completed your last visit.
- It has been up to 10 years since you were randomly assigned to a group in that trial.
- You did not receive the study treatment (ProtheraCytes) if you were in that group.
- You do not have any other health condition that would make it hard to take part or give informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is a long-term check-in for people who survived a heart attack and already took part in an earlier study through a 1-year follow-up. The goal is to learn what happens over time after the heart attack and how participants are doing.
This study checks on people who have already received a treatment called Hearticellgram-AMI for heart attack. It wants to see how they are doing over the long term.
This study follows people after an acute heart attack (AMI) to learn what care is used and what outcomes happen over time. Your information may help doctors optimize how heart attack care is delivered in the future.
This Phase 1 study is a follow-up “rollover” for people who already completed the 12-month visit of an earlier study. It checks what happens next after that prior study and may help doctors understand the ongoing safety and effects of the treatment.
This study checks how people are doing long-term after receiving NTLA-2001 in an Intellia clinical trial. If you previously took part and agree to be followed, this may help the researchers understand lasting safety and effects.
This study follows people who have had a heart attack or chest pain to learn more about their long-term health. It may help improve care for future patients.
Hear when a new Acute Myocardial Infarction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.